Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,686.00
(
-0.46%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
110.46
(
3.64%
)
Bitcoin
70,032.18
(
-1.70%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 49889

Monday, 01/21/2008 5:29:14 PM

Monday, January 21, 2008 5:29:14 PM

Post# of 257257
FDA approves Tekturna HCT, a combination of
Tekturna and the generic diuretic, hydrochlorothiazide:

http://biz.yahoo.com/prnews/080121/nym022.html

Tekturna HCT is a minor approval for NVS. The Tekturna combination pill NVS really wants is Tekturna+Diovan, but this became less likely to pass regulatory muster a few months ago (#msg-21404460).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now